152 related articles for article (PubMed ID: 1310883)
1. Two biochemical indices of mouse bone formation are increased, in vivo, in response to calcitonin.
Farley JR; Hall SL; Herring S; Tarbaux NM
Calcif Tissue Int; 1992 Jan; 50(1):67-73. PubMed ID: 1310883
[TBL] [Abstract][Full Text] [Related]
2. The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation.
Farley JR; Tarbaux NM; Hall SL; Linkhart TA; Baylink DJ
Endocrinology; 1988 Jul; 123(1):159-67. PubMed ID: 3383771
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.
Farley JR; Hall SL; Tarbaux NM
Calcif Tissue Int; 1989 Oct; 45(4):214-21. PubMed ID: 2509008
[TBL] [Abstract][Full Text] [Related]
4. Skeletal alkaline phosphatase activity as a bone formation index in vitro.
Farley JR; Baylink DJ
Metabolism; 1986 Jun; 35(6):563-71. PubMed ID: 3012246
[TBL] [Abstract][Full Text] [Related]
5. Decreased responsiveness to chronic salmon calcitonin treatment in rat kidney and calvaria studied using quantitative enzyme cytochemistry.
Salmon DM; Azria M; Zanelli JM
Acta Endocrinol (Copenh); 1985 Apr; 108(4):570-6. PubMed ID: 3158145
[TBL] [Abstract][Full Text] [Related]
6. Separation of two bone cell populations from fetal rat calvaria and a study of their responses to parathyroid hormone and calcitonin.
Braidman IP; Anderson DC; Jones CJ; Weiss JB
J Endocrinol; 1983 Dec; 99(3):387-99. PubMed ID: 6315850
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin acutely increases net 45Ca uptake and alters alkaline phosphatase specific activity in human osteosarcoma cells.
Farley JR; Hall SL; Herring S
Metabolism; 1993 Jan; 42(1):97-104. PubMed ID: 8383275
[TBL] [Abstract][Full Text] [Related]
10. Collagenase, procollagenase and bone resorption. Effects of heparin, parathyroid hormone and calcitonin.
Lenaers-Claeys G; Vaes G
Biochim Biophys Acta; 1979 May; 584(3):375-88. PubMed ID: 222339
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of mammalian thyrocalcitonin on bone growth and alkaline phosphatase activity in the chick embryo.
McWhinnie DJ
Comp Biochem Physiol A Comp Physiol; 1975 Jan; 50(1A):169-75. PubMed ID: 234049
[No Abstract] [Full Text] [Related]
12. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption.
Eeckhout Y; Delaissé JM; Vaes G
Biochem J; 1986 Nov; 239(3):793-6. PubMed ID: 3030273
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cytochemical responses to exogenously administered calcitonins in rat kidney and bone cells.
Salmon DM; Azria M; Zanelli JM
Mol Cell Endocrinol; 1983 Dec; 33(2-3):293-304. PubMed ID: 6228449
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of calcitonin on bone formation in man.
Krane SM; Harris ED; Singer FR; Potts JT
Metabolism; 1973 Jan; 22(1):51-8. PubMed ID: 4734129
[No Abstract] [Full Text] [Related]
15. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
[TBL] [Abstract][Full Text] [Related]
16. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells.
Farley JR; Wergedal JE; Baylink DJ
Science; 1983 Oct; 222(4621):330-2. PubMed ID: 6623079
[TBL] [Abstract][Full Text] [Related]
17. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
Hock JM; Hummert JR; Boyce R; Fonseca J; Raisz LG
J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bone collagen synthesis by the tumor promoter phorbol 12-myristate 13-acetate.
Feyen JH; Petersen DN; Kream BE
J Bone Miner Res; 1988 Apr; 3(2):173-9. PubMed ID: 3213612
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo.
Lau KH; Nakade O; Barr B; Taylor AK; Houchin K; Baylink DJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2347-53. PubMed ID: 7629228
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation.
Beresford JN; Gallagher JA; Russell RG
Endocrinology; 1986 Oct; 119(4):1776-85. PubMed ID: 3489608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
